Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Proteins from stem cells improved hair growth in patients with hair loss.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

The normal human prostate does not significantly affect blood DHT levels.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Tumescent liposuction is safe and effective for different cosmetic surgeries if done within recommended limits.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.